PASS THROUGH TRANSPARENT PRICING

PREDICTABLE DRUG COSTS

Pharmacy benefit managers are under intense scrutiny. The genesis of this scrutiny is complicated pricing models that hide the PBMs revenue in the cost of the medication. What the pharmacy is paid for a drug, discounts from drug manufacturers, and other costs are not traditionally shared with clients. This can lead to unpredictable spend and misaligned incentives.

Araya uses a pass-through, transparent business model as we contract to provide pharmacy benefit management services. In short this means: the client pays Araya what the pharmacy is paid. The amount billed/paid will not be adjusted pre or post adjudication by rebates, copay assistance programs or DIR fees. Rebates collected by Araya are passed directly to the client.

Araya’s only compensation will be its flat, inclusive administrative fee. The client will know exactly what they are paying for medications and exactly what they are paying for administrative fees.

FIND OUT WHAT YOU ARE MISSING

If you are not sure if your PBM contract is pass-through and transparent, then it probably isn’t. Three PBMs dominate the industry with almost 85% market share. These three PBMs seldom offer a transparent pass-through contract. With a few months of prescription data, Araya can evaluate your current deal and show you what you are leaving in the table.

Savings are out there. Send us the data and we’ll do the rest.

Shopping Basket